Diabetes Digital Support Smartpatient recently launched a digital support program for people living with Type 2 diabetes in Germany in collaboration with Novo Nordisk. This indicates a strong opportunity to upsell or expand digital patient engagement solutions for diabetes management with additional pharma partners and in new regions.

Dermatology Partnering A partnership with UCB Biopharma to offer a digital health companion for psoriasis demonstrates a track record of disease-specific modules and indicates potential to extend similar tailored programs to other dermatology and chronic disease brands seeking patient adherence and education.

MyTherapy Ecosystem With MyTherapy as a widely adopted medication management app used by millions, there is substantial cross-sell potential to onboard more pharma partners onto the ecosystem, leveraging existing digital activation, support, dispensing, and real-world insights capabilities.

Global Expansion Readiness The company functions within a scalable, compliant framework designed for direct-to-patient engagement, suggesting readiness to support multinational pharma campaigns and country-specific customization, expanding addressable markets beyond Germany.

MedTech Collaboration Recent collaborations and disease-specific modules point to opportunities to package modular patient support solutions for new indications, enabling pharma partners to accelerate patient engagement, adherence programs, and measurable outcomes across the patient journey.